LB Pharmaceuticals Inc
LBRXNasdaqCIK 1691082HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | period not labelled2024-03-31 | period not labelled2024-06-30 | period not labelled2024-09-30 | period not labelled2024-12-31 | period not labelled2025-03-31 | period not labelled2025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | $m | not reported | not reported | 10.7Research and development, period not labelled, three months to 2024-09-30$10.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | 0.4Research and development, period not labelled, three months to 2024-12-31$376.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001193125-26-126368. Derived: 12-month figure less the 9-month figure.Report this figure | 3.4Research and development, period not labelled, three months to 2025-03-31$3.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | 2.4Research and development, period not labelled, three months to 2025-06-30$2.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | 2.4Research and development, Q3 FY2025, three months to 2025-09-30$2.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | 8.5Research and development, Q4 FY2025, three months to 2025-12-31$8.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001193125-26-126368. Derived: 12-month figure less the 9-month figure.Report this figure | 14.6Research and development, Q1 FY2026, three months to 2026-03-31$14.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | 44.1Research and development, Q2 FY2026, three months to 2026-06-30$44.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure |
| Income tax | $m | not reported | not reported | 0.0Income tax, period not labelled, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | 0.0Income tax, period not labelled, three months to 2024-12-31$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-26, accession 0001193125-26-126368. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Income tax, period not labelled, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | 0.0Income tax, period not labelled, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | 0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | 0.0Income tax, Q4 FY2025, three months to 2025-12-31$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-26, accession 0001193125-26-126368. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | 0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure |
| Net income | $m | (16.2)Net income, period not labelled, three months to 2024-03-31−$16.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | (27.6)Net income, period not labelled, three months to 2024-06-30−$27.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | (14.2)Net income, period not labelled, three months to 2024-09-30−$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | (5.1)Net income, period not labelled, three months to 2024-12-31−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-126368. Derived: 12-month figure less the 9-month figure.Report this figure | (5.3)Net income, period not labelled, three months to 2025-03-31−$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | (4.9)Net income, period not labelled, three months to 2025-06-30−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | (3.6)Net income, Q3 FY2025, three months to 2025-09-30−$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | (11.5)Net income, Q4 FY2025, three months to 2025-12-31−$11.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001193125-26-126368. Derived: 12-month figure less the 9-month figure.Report this figure | (19.1)Net income, Q1 FY2026, three months to 2026-03-31−$19.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | (51.6)Net income, Q2 FY2026, three months to 2026-06-30−$51.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure |
| Diluted EPS | $ per share | not reported | not reported | (39.49)Diluted EPS, period not labelled, three months to 2024-09-30−$39.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | not reported | (14.79)Diluted EPS, period not labelled, three months to 2025-03-31−$14.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | (13.58)Diluted EPS, period not labelled, three months to 2025-06-30−$13.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | (0.61)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | not reported | (0.67)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | (1.71)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure |
| Basic EPS | $ per share | not reported | not reported | (39.49)Basic EPS, period not labelled, three months to 2024-09-30−$39.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | not reported | (14.79)Basic EPS, period not labelled, three months to 2025-03-31−$14.79 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | (13.58)Basic EPS, period not labelled, three months to 2025-06-30−$13.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | (0.61)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | not reported | (0.67)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.67 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | (1.71)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure |
Balance sheet
| Line item | Unit | period not labelled2023-12-31 | period not labelled2024-03-31 | period not labelled2024-06-30 | period not labelled2024-09-30 | period not labelled2024-12-31 | period not labelled2025-03-31 | period not labelled2025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | 23.0Cash and equivalents, period not labelled, at 2024-12-31$23.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-26, accession 0001193125-26-126368.Report this figure | not reported | not reported | 270Cash and equivalents, Q3 FY2025, at 2025-09-30$269.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | 250Cash and equivalents, FY2025, at 2025-12-31$250.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | 321Cash and equivalents, Q1 FY2026, at 2026-03-31$320.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | 283Cash and equivalents, Q2 FY2026, at 2026-06-30$283.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure |
| Current assets | $m | not reported | not reported | not reported | not reported | 28.9Current assets, period not labelled, at 2024-12-31$28.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-26, accession 0001193125-26-126368.Report this figure | not reported | not reported | 316Current assets, Q3 FY2025, at 2025-09-30$316.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | 308Current assets, FY2025, at 2025-12-31$308.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | 389Current assets, Q1 FY2026, at 2026-03-31$389.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | 355Current assets, Q2 FY2026, at 2026-06-30$355.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure |
| Total assets | $m | not reported | not reported | not reported | not reported | 33.5Total assets, period not labelled, at 2024-12-31$33.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-26, accession 0001193125-26-126368.Report this figure | not reported | not reported | 321Total assets, Q3 FY2025, at 2025-09-30$320.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | 313Total assets, FY2025, at 2025-12-31$312.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | 393Total assets, Q1 FY2026, at 2026-03-31$393.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | 362Total assets, Q2 FY2026, at 2026-06-30$361.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure |
| Current liabilities | $m | not reported | not reported | not reported | not reported | 8.1Current liabilities, period not labelled, at 2024-12-31$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-26, accession 0001193125-26-126368.Report this figure | not reported | not reported | 6.6Current liabilities, Q3 FY2025, at 2025-09-30$6.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | 7.4Current liabilities, FY2025, at 2025-12-31$7.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | 10.9Current liabilities, Q1 FY2026, at 2026-03-31$10.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | 23.6Current liabilities, Q2 FY2026, at 2026-06-30$23.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure |
| Total liabilities | $m | not reported | not reported | not reported | not reported | 13.8Total liabilities, period not labelled, at 2024-12-31$13.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-26, accession 0001193125-26-126368.Report this figure | not reported | not reported | 10.5Total liabilities, Q3 FY2025, at 2025-09-30$10.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | 11.6Total liabilities, FY2025, at 2025-12-31$11.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | 14.8Total liabilities, Q1 FY2026, at 2026-03-31$14.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | 29.3Total liabilities, Q2 FY2026, at 2026-06-30$29.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure |
| Shareholders' equity | $m | (34.5)Shareholders' equity, period not labelled, at 2023-12-31−$34.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-26, accession 0001193125-26-126368.Report this figure | (50.4)Shareholders' equity, period not labelled, at 2024-03-31−$50.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | (77.4)Shareholders' equity, period not labelled, at 2024-06-30−$77.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | (91.5)Shareholders' equity, period not labelled, at 2024-09-30−$91.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | (94.6)Shareholders' equity, period not labelled, at 2024-12-31−$94.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | (99.3)Shareholders' equity, period not labelled, at 2025-03-31−$99.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | (104)Shareholders' equity, period not labelled, at 2025-06-30−$103.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | 310Shareholders' equity, Q3 FY2025, at 2025-09-30$310.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268174.Report this figure | 301Shareholders' equity, FY2025, at 2025-12-31$301.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | 379Shareholders' equity, Q1 FY2026, at 2026-03-31$378.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure | 332Shareholders' equity, Q2 FY2026, at 2026-06-30$332.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-343490.Report this figure |
Cash flow
| Line item | Unit | period not labelled2024-12-31 | period not labelled2025-03-31 | period not labelled2025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $m | (5.7)Operating cash flow, period not labelled, three months to 2024-12-31−$5.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001193125-26-126368. Derived: 12-month figure less the 9-month figure.Report this figure | (8.1)Operating cash flow, period not labelled, three months to 2025-03-31−$8.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | (5.6)Operating cash flow, period not labelled, three months to 2025-06-30−$5.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343490. Derived: 6-month figure less the 3-month figure.Report this figure | (3.4)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268174. Derived: 9-month figure less the 6-month figure.Report this figure | (18.1)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$18.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001193125-26-126368. Derived: 12-month figure less the 9-month figure.Report this figure | (23.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$23.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | (37.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$37.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-343490. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $m | 0.2Capital expenditure, period not labelled, three months to 2024-12-31$238.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001193125-26-126368. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Capital expenditure, period not labelled, three months to 2025-03-31$21.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | (0.0)Capital expenditure, period not labelled, three months to 2025-06-30−$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343490. Derived: 6-month figure less the 3-month figure.Report this figure | 0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268174. Derived: 9-month figure less the 6-month figure.Report this figure | 0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$40.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001193125-26-126368. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$32.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001193125-26-219607.Report this figure | 0.4Capital expenditure, Q2 FY2026, three months to 2026-06-30$363.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-343490. Derived: 6-month figure less the 3-month figure.Report this figure |
Shares
| Line item | Unit | period not labelled2024-09-30 | period not labelled2025-03-31 | period not labelled2025-06-30 | Q3 FY20252025-09-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 0.4 | 0.4 | 0.4 | 5.8 | 28.2 | 30.1 |
Shares outstanding: 32.26m at Aug 5, 2026, from the cover of the 10-Q filed Aug 11, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.